hVIVO plc (LON:HVO – Get Free Report)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 28.06 ($0.35) and traded as high as GBX 28.10 ($0.35). hVIVO shares last traded at GBX 27.95 ($0.35), with a volume of 472,093 shares trading hands.
hVIVO Trading Up 0.2 %
The firm has a 50-day moving average of GBX 28.08 and a 200 day moving average of GBX 24.89. The company has a market cap of £190.50 million, a P/E ratio of -1.00 and a beta of 0.99. The company has a current ratio of 1.46, a quick ratio of 1.16 and a debt-to-equity ratio of 9.83.
hVIVO Cuts Dividend
The firm also recently declared a dividend, which will be paid on Monday, May 20th. Shareholders of record on Thursday, April 18th will be issued a dividend of GBX 0.20 ($0.00) per share. This represents a dividend yield of 0.68%. The ex-dividend date is Thursday, April 18th.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 4/29 – 5/3
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Learn Technical Analysis Skills to Master the Stock Market
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.